Stay updated on Belvarafenib in NRAS-Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page.

Latest updates to the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page
- Check3 days agoChange DetectedOn 2025-12-31, new History entries were added for Contacts/Locations and Study Status; the version count shows 43 on 2025-12-30, and an entry dated 2025-09-30 was removed.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. No study data or core functionality was affected.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision update from v3.3.1 to v3.3.2 with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedFooter now displays Revision: v3.3.1 instead of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedRemoved the site-wide operating-status notice about funding from the page. This change does not affect the trial record data or the history of the record.SummaryDifference0.4%

- Check68 days agoChange DetectedThe new screenshots show additional history entries in the Record History, with no visible changes to core study details, status, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Belvarafenib in NRAS-Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page.